Skip to content

Drug interactions

Ceritinib + Linagliptin

Severity: Minor

Ceritinib and Linagliptin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ceritinib inhibits CYP3A4 and may increase linagliptin exposure. Because linagliptin is largely eliminated unchanged, the effect is likely small. Ceritinib itself can cause hyperglycemia.

What this interaction means in plain words

Ceritinib and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ceritinib belongs to Oncology; Linagliptin belongs to Endocrine.

Evidence level: Low

Why it happens

CYP3A4 inhibition by ceritinib modestly reduces linagliptin metabolism.

What to do

No dose change needed; monitor blood glucose given ceritinib-related hyperglycemia.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ceritinib and Linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ceritinib with Linagliptin?

MediHelp rates the interaction as minor. Ceritinib and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ceritinib inhibits CYP3A4 and may increase linagliptin exposure. Because linagliptin is largely eliminated unchanged, the effect is likely small. Ceritinib itself can cause hyperglycemia.

How serious is the interaction between Ceritinib and Linagliptin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change needed; monitor blood glucose given ceritinib-related hyperglycemia.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in